Current Diabetes Reports

, Volume 9, Issue 3, pp 185–187

ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks

Authors

  • HoWon Lee
  • Amgad N. Makaryus
  • Samy I. McFarlane
Clinical Trials Report

DOI: 10.1007/s11892-009-0030-9

Cite this article as:
Lee, H., Makaryus, A.N. & McFarlane, S.I. Curr Diab Rep (2009) 9: 185. doi:10.1007/s11892-009-0030-9

Copyright information

© Current Medicine Group, LLC 2009